minimum age for glp 1 and Semaglutide: When to Start GLP-1 Therapy GLP-1 RA education

India bears one of the highest burdens of type 2 diabetes globally, earning it the informal title of the diabetes capital of the world. The World Health Organisation (WHO) estimates that around 77 million Indian adults live with type 2 diabetes, while another 25 million are considered prediabetic, facing a heightened risk of developing the disease soon

Tirzepatide is administered as a once-weekly subcutaneous injection, with doses ranging from 2.5 mg to 15 mg

Semaglutide handles the heavy lifting of GLP-1 receptor activation and appetite regulation

10.1038/nrd.2016.153 61 WoodcockJ.LaVangeL

Results Each propensity-score matched group constituted 3424 patients, 45% women, 21% had a history of cardiovascular disease, and 13.9% were treated with sodium-glucose cotransporter-2 inhibitors at baseline

Effect of exenatide on splanchnic and peripheral glucose metabolism in type 2 diabetic subjects